Page last updated: 2024-09-03

flag peptide and osteoprotegerin

flag peptide has been researched along with osteoprotegerin in 1 studies

Compound Research Comparison

Studies
(flag peptide)
Trials
(flag peptide)
Recent Studies (post-2010)
(flag peptide)
Studies
(osteoprotegerin)
Trials
(osteoprotegerin)
Recent Studies (post-2010) (osteoprotegerin)
54411075,1082122,726

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appelbaum, ER; Burke, MB; Deen, KC; DiPrinzio, R; Dodds, RA; Dul, E; Eichman, C; Emery, JG; James, IE; Lee, JC; Lyn, S; McDonnell, P; Rosenberg, M; Silverman, C; Young, PR1

Other Studies

1 other study(ies) available for flag peptide and osteoprotegerin

ArticleYear
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.
    The Journal of biological chemistry, 1998, Jun-05, Volume: 273, Issue:23

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Binding, Competitive; Glycoproteins; GPI-Linked Proteins; Humans; Immunoglobulin Fc Fragments; Immunohistochemistry; Jurkat Cells; Ligands; Membrane Glycoproteins; Mice; Microscopy, Fluorescence; Oligopeptides; Osteoclasts; Osteoprotegerin; Peptides; Protein Binding; Receptors, Cytoplasmic and Nuclear; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; Receptors, Tumor Necrosis Factor, Member 25; Recombinant Fusion Proteins; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha

1998